• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Werewolf Therapeutics, Inc. - Common Stock (NQ:HOWL)

0.6400 -0.0200 (-3.03%)
Official Closing Price Updated: 4:15 PM EST, Feb 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 841,977
Open 0.6400
Bid (Size) 0.6300 (300)
Ask (Size) 0.6600 (10,000)
Prev. Close 0.6600
Today's Range 0.6300 - 0.6900
52wk Range 0.5301 - 2.380
Shares Outstanding 27,567,728
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
February 24, 2026
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives ↗
February 13, 2026
The company said that the decision to layoff 64% of its workforce was approved by its board of directions on Feb. 9. 
Via Stocktwits
Topics Workforce

Performance

YTD
-0.7%
-0.7%
1 Month
-1.3%
-1.3%
3 Month
-34.5%
-34.5%
6 Month
-51.9%
-51.9%
1 Year
-50.0%
-50.0%

More News

Read More
News headline image
Top movers in Thursday's session ↗
December 18, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
December 18, 2025
Via Chartmill
One Patient's Complete Response to Investigational Cancer Therapy Sparks Hope
August 14, 2025
Via Brandpoint
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
December 18, 2025
Via Chartmill
News headline image
Werewolf Therapeutics Announces Pipeline and Business Updates
December 18, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
November 07, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
November 05, 2025
Via Benzinga
News headline image
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 04, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
October 08, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
October 03, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
September 23, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 22, 2025
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
September 22, 2025
Via Chartmill
News headline image
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Reports No Revenue in Fiscal Q2 ↗
August 14, 2025
Via The Motley Fool
News headline image
Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
July 09, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics to Participate in the BIO International Convention
June 12, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
May 29, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Top movers in Tuesday's after hours session ↗
May 20, 2025
Via Chartmill
News headline image
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
May 20, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit
May 13, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Werewolf Therapeutics, Inc. - Common Stock publicly traded?
Yes, Werewolf Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Werewolf Therapeutics, Inc. - Common Stock trade on?
Werewolf Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Werewolf Therapeutics, Inc. - Common Stock?
The ticker symbol for Werewolf Therapeutics, Inc. - Common Stock is HOWL on the Nasdaq Stock Market
What is the current price of Werewolf Therapeutics, Inc. - Common Stock?
The current price of Werewolf Therapeutics, Inc. - Common Stock is 0.6400
When was Werewolf Therapeutics, Inc. - Common Stock last traded?
The last trade of Werewolf Therapeutics, Inc. - Common Stock was at 02/25/26 04:15 PM ET
What is the market capitalization of Werewolf Therapeutics, Inc. - Common Stock?
The market capitalization of Werewolf Therapeutics, Inc. - Common Stock is 17.64M
How many shares of Werewolf Therapeutics, Inc. - Common Stock are outstanding?
Werewolf Therapeutics, Inc. - Common Stock has 18M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap